Coverage
-
January 23, 2017
GlaxoSmithKline PLC sought summary judgment Friday to end the six remaining cases against the pharmaceutical company in multidistrict litigation over the health effects of zinc used in denture cream products, arguing that the plaintiffs have not shown how the products cause neurological damage.
15 other articles on this case.
View all »